-
81
4-1BB agonist targeted to fibroblast activation protein α synergizes with radiotherapy to treat murine breast tumor models
Published 2025-02-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
82
Divergent response to radio-immunotherapy is defined by intrinsic features of the tumor microenvironment
Published 2025-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
83
Phase Ib study of pembrolizumab in combination with trastuzumab emtansine for metastatic HER2-positive breast cancer
Published 2022-10-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
84
Association of immune-related adverse events with the outcomes of immune checkpoint inhibitors in patients with dMMR/MSI-H metastatic colorectal cancer
Published 2023-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
85
Influence of injection technique, drug formulation and tumor microenvironment on intratumoral immunotherapy delivery and efficacy
Published 2021-02-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
86
Stratification system with dual human endogenous retroviruses for predicting immunotherapy efficacy in metastatic clear-cell renal cell carcinoma
Published 2025-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
87
Role of Fcγ receptors in HER2-targeted breast cancer therapy
Published 2022-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
88
STING agonism overcomes STAT3-mediated immunosuppression and adaptive resistance to PARP inhibition in ovarian cancer
Published 2023-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
89
Identification of HPV16 E1 and E2-specific T cells in the oropharyngeal cancer tumor microenvironment
Published 2023-03-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
90
Shed antigen-induced blocking effect on CAR-T cells targeting Glypican-3 in Hepatocellular Carcinoma
Published 2021-04-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
91
Pan-tumor analysis to investigate the obesity paradox in immune checkpoint blockade
Published 2025-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
92
TCF1-positive and TCF1-negative TRM CD8 T cell subsets and cDC1s orchestrate melanoma protection and immunotherapy response
Published 2024-07-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
93
Immunotherapy-associated autoimmune hemolytic anemia
Published 2017-02-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
94
Statin drugs enhance responses to immune checkpoint blockade in head and neck cancer models
Published 2023-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
95
Oncolytic immunotherapy: multiple mechanisms of oncolytic peptides to confer anticancer immunity
Published 2022-07-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
96
Complete metabolic response as early predictor of long-term efficacy after adoptive T cell therapy using tumor-infiltrating lymphocytes
Published 2025-02-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
97
Phase Ib open-label, multicenter study of pixatimod, an activator of TLR9, in combination with nivolumab in subjects with microsatellite-stable metastatic colorectal cancer, metast...
Published 2023-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
98
Novel combination strategy of high intensity focused ultrasound (HIFU) and checkpoint blockade boosted by bioinspired and oxygen-supplied nanoprobe for multimodal imaging-guided ca...
Published 2023-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
99
Durable responders in advanced NSCLC with elevated TMB and treated with 1L immune checkpoint inhibitor: a real-world outcomes analysis
Published 2023-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
100
Tumor mutational burden quantification from targeted gene panels: major advancements and challenges
Published 2019-07-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article